Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Clinical trials sponsored by Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh, explained in plain language.
-
New hope for scleroderma patients: tofacitinib takes on skin thickening
Disease control CompletedThis study tested whether tofacitinib, a drug that calms the immune system, works better than methotrexate for reducing skin thickening in people with a severe form of scleroderma. 34 adults with early-stage diffuse scleroderma took part. The main goal was to measure changes in s…
Phase: PHASE4 • Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Guava leaf mouthwash takes on chlorhexidine in gum health showdown
Disease control CompletedThis study tested whether a mouthwash made from guava leaf extract works as well as a standard chlorhexidine mouthwash for treating chronic gingivitis (gum disease). 160 adults with moderate to severe gum inflammation used one of the two rinses. Researchers measured plaque buildu…
Phase: NA • Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Could a simple dose change help women with PCOS get pregnant?
Disease control CompletedThis study looked at whether a step-up dose of the drug letrozole helps women with PCOS ovulate better than the standard low dose. 70 infertile women with PCOS took either the step-up or standard dose for up to 3 menstrual cycles. Researchers tracked follicle growth, uterine lini…
Phase: PHASE3 • Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
Vitamin B3 shows promise in cutting migraine days
Symptom relief CompletedThis study tested whether adding nicotinic acid (a form of vitamin B3) to standard beta-blocker treatment could reduce the number of migraine days in people with moderate to severe migraines. Fifty-eight adults took either a low dose, high dose, or placebo for 12 weeks. The goal …
Phase: PHASE2 • Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh • Aim: Symptom relief
Last updated May 11, 2026 20:41 UTC
-
Knee pain relief: l-carnitine shows promise in new study
Symptom relief CompletedThis study tested whether L-carnitine, a natural substance, can reduce pain, stiffness, and improve physical function in people with mild to moderate knee osteoarthritis. 66 adults took either L-carnitine or a placebo daily. Researchers measured symptoms and checked markers of in…
Phase: PHASE2 • Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh • Aim: Symptom relief
Last updated May 06, 2026 16:03 UTC
-
Can a smartphone app curb antibiotic overuse in bangladesh?
Knowledge-focused CompletedThis study tested a digital system called SmartAMR in community pharmacies in Bangladesh. The system includes real-time records, symptom checks, and medication reminders. Researchers wanted to see if it was practical and could help reduce the misuse of antibiotics. The study invo…
Phase: NA • Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh • Aim: Knowledge-focused
Last updated May 12, 2026 13:47 UTC